Exposure to the RXR agonist SR11237 in early life causes disturbed skeletal morphogenesis in a rat model
Holly Dupuis, Michael Andrew Pest, Ermina Hadzic, Thin Xuan Vo, Daniel Barry Hardy, Frank Beier
This study shows that RXR agonist SR11237 disrupts skeletal development in rats and mice by causing growth plate dysmorphia and impaired long bone growth.
International Journal of Molecular Sciences · Oct 20, 2019Peer-reviewedDevelopmental Biology